INNOVATION THAT MATTERS

Brave Science: Putting the ‘Hutzpah’ in Early-Stage Drug Discovery

By Rich Soll, SVP of Research Service Division at WuXi AppTec (@richsollwx) From developing new paradigms for early-stage drug discovery for rare and common diseases to fostering the convergence of peptide nanotechnology, and launching...

INDUSTRY BEATS

THE LAUNCHPAD

WUXI NEWS

LabNetwork Integrates with Reaxys to Offer Seamless Experience from Chemistry Research to Purchase

We look forward to the new collaboration between LabNetwork, WuXi AppTec’s global chemistry ecommerce platform company, and Elsevier, a world-leading provider of scientific, technical and medical information products and services. Under the...

WuXi Biologics Receives Asia-Pacific Best Bioprocessing Excellence Award from IMAPAC

We are pleased to announce that WuXi Biologics  has received the 2017 Asia-Pacific Best Bioprocessing Excellence Award from IMAPAC, a leading consulting firm. WuXi Biologics has been recognized for its outstanding performance for...

FDA DRUG APPOVALS / DESIGNATIONS

SPOTLIGHT

STAY CONNECTED

Twitter LinkedIn 

INNOVATION THAT MATTERS